Your browser doesn't support javascript.
loading
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
Jaimes Campos, Mayra Alejandra; Andújar, Iván; Keller, Felix; Mayer, Gert; Rossing, Peter; Staessen, Jan A; Delles, Christian; Beige, Joachim; Glorieux, Griet; Clark, Andrew L; Mullen, William; Schanstra, Joost P; Vlahou, Antonia; Rossing, Kasper; Peter, Karlheinz; Ortiz, Alberto; Campbell, Archie; Persson, Frederik; Latosinska, Agnieszka; Mischak, Harald; Siwy, Justyna; Jankowski, Joachim.
Afiliación
  • Jaimes Campos MA; Mosaiques Diagnostics GmbH, 30659 Hannover, Germany.
  • Andújar I; Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, 52074 Aachen, Germany.
  • Keller F; Proteomic Laboratory, Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba.
  • Mayer G; Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Rossing P; Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, 6020 Innsbruck, Austria.
  • Staessen JA; Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
  • Delles C; Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Beige J; Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, 2800 Mechlin, Belgium.
  • Glorieux G; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow G12 8TA, UK.
  • Clark AL; Division of Nephrology and KfH Renal Unit, Hospital St Georg, 04129 Leipzig, Germany.
  • Mullen W; Medical Clinic 2, Martin-Luther-University Halle/Wittenberg, 06112 Halle, Germany.
  • Schanstra JP; Nephrology Section, Department of Internal Medicine, Ghent University Hospital, 9000 Ghent, Belgium.
  • Vlahou A; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham HU16 5JQ, UK.
  • Rossing K; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow G12 8TA, UK.
  • Peter K; Institut National de la Santé et de la Recherche Médicale, Institute of Cardiovascular and Metabolic Disease, UMRS 1297, 31432 Toulouse, France.
  • Ortiz A; Renal Fibrosis, Université Toulouse III Paul-Sabatier, Route de Narbonne, 31062 Toulouse, France.
  • Campbell A; Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), 115 27 Athens, Greece.
  • Persson F; Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Latosinska A; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Mischak H; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia.
  • Siwy J; Department of Physiology, Anatomy, Microbiology, La Trobe University, Melbourne, VIC 3083, Australia.
  • Jankowski J; Department of Medicine and Immunology, Monash University, Melbourne, VIC 3800, Australia.
Pharmaceuticals (Basel) ; 16(9)2023 Sep 14.
Article en En | MEDLINE | ID: mdl-37765106
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza